MELANIE HORNUNG: Open Payments
NPI 1922755578 · SPRINGFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,817 in 92 payments from 23 companies in 2025. Trend: 2023 $1,925 · 2024 $1,829 · 2025 $1,817
Food & beverage: $1,784Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $297 |
| Axsome Therapeutics, Inc. | 6 | $177 |
| Novo Nordisk Inc | 8 | $176 |
| AstraZeneca Pharmaceuticals LP | 8 | $161 |
| Lundbeck LLC | 7 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $114 |
| Lilly USA, LLC | 5 | $103 |
| Amgen Inc. | 4 | $89 |
| PFIZER INC. | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
Products named: REXULTI, Auvelity, UBRELVY, QULIPTA, Kerendia, MOUNJARO, Wegovy, Ozempic.
Industry payments across VA — which companies pay providers there.
